Biosequence

BioSequence is an Ecuador-based genetics and genomics company that connects science and healthcare through advanced DNA and RNA sequencing. A pioneer in next-generation sequencing (NGS) in Ecuador, the company serves healthcare professionals, researchers, institutions, and private businesses. It reports more than 100 sequencing projects completed in the country, over 3,000 samples processed, and more than three years advising clients.

Its services include human genetic testing for hereditary and somatic cancers, inherited heart conditions, pharmacogenetics, paternity, and human gut microbiota. BioSequence also offers microbiology and soil microbiota studies, using sequencing to identify microorganisms and explore their roles in health, soil fertility, and agricultural productivity. Its analyses can identify clinically relevant genetic variants, assess medication response, and support personalized diagnostic and treatment decisions.

The company’s local team includes specialists in biotechnology, genetics, pathology, molecular biology, and microbiology. BioSequence provides guidance from sample collection through results interpretation, with local processing, sample traceability, and stated turnaround times of 21 to 30 days. Its laboratories and offices serve clients in Quito and Guayaquil.